NovoCure
NVCR
NVCR
129 hedge funds and large institutions have $959M invested in NovoCure in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 128 → 129 (+1)
11% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 46
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
129
Holding in Top 10
4
Calls
$32M
Puts
$4.08M
Top Buyers
| 1 | +$46.8M | |
| 2 | +$18.6M | |
| 3 | +$18.5M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$16.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.3M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$9.69M | |
| 3 | -$5.45M | |
| 4 |
Millennium Management
New York
|
-$5.17M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.56M |